Inappropriate sinus tachycardia: Current therapeutic options

Cardiology in Review

Volumn 20, Issue 1, 2012, Pages 8-14

  Femenía, Francisco ^a   Baranchuk, Adrian ^b   Morillo, Carlos A ^c  

^a HOSPITAL ESPAÑOL DE MENDOZA   (Argentina)

^b QUEEN S UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

inappropriate sinus tachycardia; ivabradine

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; FLUDROCORTISONE; IVABRADINE; MIDODRINE; PYRIDOSTIGMINE; RESERPINE;

ABLATION THERAPY; CARDIOMYOPATHY; CLINICAL FEATURE; ELECTROPHYSIOLOGY; FOLLOW UP; HEART FUNCTION; HEART REHABILITATION; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; RADIOFREQUENCY IDENTIFICATION; REVIEW; SINUS NODE; SINUS TACHYCARDIA; TACHYCARDIOMYOPATHY;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART FUNCTION TESTS; HUMANS; MEDICAL HISTORY TAKING; STOCKINGS, COMPRESSION; TACHYCARDIA, SINUS;

EID: 83155184618     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31822f0b3e     Document Type: Review

References (68)

1. Still AM, Raatikainen P, Ylitalo A, et al. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace. 2005;7:104-112. (Pubitemid 40347853)
2. Morillo CA, Klein GJ, Thakur RK, et al. Mechanism of 'inappropriate' sinus tachycardia. Role of sympathovagal balance. Circulation. 1994;90:873-877. (Pubitemid 24242757)
3. Leon H, Guzman JC, Kuusela T, et al. Impaired baroreflex gain in patients with inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2005;16:64-68. (Pubitemid 40165454)
4. Chiale PA, Garro HA, Schmidberg J, et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart Rhythm. 2006;3:1182-1186. (Pubitemid 44464147)
5. Lee RJ, Shinbane JS. Inappropriate sinus tachycardia. Diagnosis and treatment. Cardiol Clin. 1997;15:599-605. (Pubitemid 27509599)
6. Krahn AD, Yee R, Klein GJ, et al. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol. 1995;6:1124-1128. (Pubitemid 26025399)
7. Morillo CA, Guzmán JC. Taquicardia sinusal inapropiada: actualización. Rev Esp Cardiol. 2007;60(suppl 3):10-14.
8. Bauernfeind RA, Amat-Y-Leon F, Dhingra RC, et al. Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons. Ann Intern Med. 1979;91:702-710. (Pubitemid 10218040)
9. Shen WK, Low PA, Jahangir A, et al. Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol. 2001;24:217-230. (Pubitemid 32208287)
10. Still AM, Huikuri HV, Airaksinen KE, et al. Impaired negative chronotropic response to adenosine in patients with inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2002;13:557-562. (Pubitemid 34615419)
11. Zhou J, Scherlag BJ, Niu G, et al. Anatomy and physiology of the right interganglionic nerve: implications for the pathophysiology of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2008;19:971-976.
12. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997;29:709-715. (Pubitemid 27128241)
13. Brandt RR, Shen WK. Bradycardia-induced polymorphic ventricular tachycardia after atrioventricular junction ablation for sinus tachycardia-induced cardiomyopathy. J Cardiovasc Electrophysiol. 1995;6:630-633.
14. Kanjwal MY, Kosinski DJ, Grubb BP. Treatment of postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. Curr Cardiol Rep. 2003;5:402-406. (Pubitemid 38906887)
15. Brady PA, Low PA, Shen WK. Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes. Pacing Clin Electrophysiol. 2005;28:1112-1121. (Pubitemid 43951416)
16. Shen WK. How to manage patients with inappropriate sinus tachycardia. Heart Rhythm. 2005;2:1015-1019.
17. Castellanos A, Moleiro F, Chakko S, et al. Heart rate variability in inappropriate sinus tachycardia. Am J Cardiol. 1998;82:531-534. (Pubitemid 28389959)
18. Kanjwal Y, Kosinski D, Grubb BP. The postural orthostatic tachycardia syndrome: definitions, diagnosis, and management. Pacing Clin Electrophysiol. 2003;26:1747-1757. (Pubitemid 36936752)
19. Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol. 2006;17:108-112.
20. Morillo CA, Baranchuk A, Guzman JC. Sindromes de Intoleracia Ortostática Crónica (Chronic Orthostatic Intolerance Syndromes). In: Charria D, Melgarejo E, eds. Texto de Cardiologia. Chapter X. Bogota: Sociedad Colombiana de Cardiología y Cirugía Cardiovascular; 2007:923-932.
21. Morillo CA, Guzman JC. Autonomic Function Assessment. Guia Neurologica 7. Bogota: Pontificia Universidad Javeriana; 2005:214-231.
22. Morillo CA, Guzman JC. The essential autonomic assessment for evaluating the cause of syncope. In: Benditt DG, Brignole M, Raviele A, Wieling W, eds. Syncope and Transient Loss of Consciousness Multidisciplinary Management. San Francisco: Blackwell Futura; 2007. Chapter 2-8:39-44.
23. Low PA, Opfer-Gehrking TL, Textor SC, et al. Postural tachycardia syndrome (POTS). Neurology. 1995;45(4 suppl 5):S19-S25.
24. Low PA, Schondorf R, Rummans TA. Why do patients have orthostatic symptoms in POTS? Clin Auton Res. 2001;11:223-224. (Pubitemid 33043690)
25. Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23: 407-421. (Pubitemid 38437512)
26. Morillo CA, Klein GJ, Yee R, et al. Power spectral analysis of heart rate variability during passive tilt identifies patients with neurally mediated syncope. Circulation. 1992;86(suppl I):I-528 (Abstract).
27. Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220-222. (Pubitemid 11060568)
28. Malliani A, Pagani M, Lombardi F, et al. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482-492.
29. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178-193. (Pubitemid 16017873)
30. Khurana RK, Watabiki S, Hebel JR, et al. Cold face test in the assessment of trigeminal-brainstem-vagal function in humans. Ann Neurol. 1980;7:144-149. (Pubitemid 10156247)
31. Heath ME, Downey JA. The cold face test (diving reflex) in clinical autonomic assessment: methodological considerations and repeatability of responses. Clin Sci. 1990;78:139-147. (Pubitemid 20084051)
32. Hilz MJ, Dütsch M. Quantitative studies of autonomic function. Muscle Nerve. 2006;33:6-20. (Pubitemid 43062983)
33. Cleaveland CR, Rangno RE, Shand DG. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med. 1972;130:47-52.
34. Jose AD. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol. 1966;18:476-478.
35. Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 1970;4:160-167.
36. Lee RJ, Kalman JM, Fitzpatrick AP, et al. Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation. 1995;92:2919-2928.
37. Brugada P, Den Dulk K, Waldecker B, et al. Role of programmed electrical stimulation of the heart in the selection and design of implantable units for the treatment of recurrent tachycardia. Eur Heart J. 1986;7:728-734. (Pubitemid 16018790)
38. Yusuf S, Camm AJ. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven? J Cardiovasc Pharmacol Ther. 2003;8:89-105. (Pubitemid 36705499)
39. Yusuf S, Camm AJ. Deciphering the sinus tachycardias. Clin Cardiol. 2005;28:267-276. (Pubitemid 40803515)
40. DiFrancesco D. Characterization of single pacemaker channels in cardiac sinoatrial node cells. Nature. 1986;324:470-473.
41. Bucchi A, Barbuti A, Baruscotti M, et al. Heart rate reduction via selective 'funny' channel blockers. Curr Opin Pharmacol. 2007;7:208-213. (Pubitemid 46404736)
42. Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112: 37-42. (Pubitemid 24151700)
43. Simon L, Ghaleh B, Puybasset L, et al. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther. 1995;275:659-666. (Pubitemid 26023611)
44. Ragueneau I, Laveille C, Jochemsen R, et al. Pharmacokinetic- pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Clin Pharmacol Ther. 1998;64:192-203. (Pubitemid 28423855)
45. Borer JS, Fox K, Jaillon P, et al. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation. 2003;107:817-823. (Pubitemid 36241038)
46. DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res. 2006;53:399-406.
47. Tardif JC, Ford I, Tendera M, et al.; INITIATIVE Investigators. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 2005;26:2529-2536. (Pubitemid 41677303)
48. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D. 2003;4:83-89. (Pubitemid 37062655)
49. Joannides R, Moore N, Iacob M, et al. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Br J Clin Pharmacol. 2006;61:127-137. (Pubitemid 43382606)
50. Manz M, Reuter M, Lauck G, et al. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100:149-155. (Pubitemid 37465145)
51. Ruzyllo W, Tendera M, Ford I, et al. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs. 2007;67:393-405. (Pubitemid 46425552)
52. E wan V, Norton M, Newton JL. Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine. Europace. 2007;9:1202.
53. Khan S, Hamid S, Rinaldi C. Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and aVdual chamber pacemaker. Pacing Clin Electrophysiol. 2009;32: 131-133.
54. Schulze V, Steiner S, Hennersdorf M, et al. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report. Cardiology. 2008;110:206-208. (Pubitemid 351799058)
55. Retegui G, Quintero M, Ruiz-Borrell M, et al. Ivabradine as a treatment option for inappropriate sinus tachycardia. Rev Esp Cardiol. 2009;62:577-579.
56. Riccioni G. Ivabradine: from molecular basis to clinical effectiveness. Adv Ther. 2010;27:160-167.
57. Zhang R, Haverich A, Strüber M, et al. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol. 2008;97:811-819.
58. Kaplinsky E, Comes FP, Urondo LS, et al. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Cardiol J. 2010;17:166-171.
59. Fox K, Ford I, Steg PG, et al. BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebocontrolled trial. Lancet. 2008;372:807-816.
60. Calò L, Rebecchi M, Sette A, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm. 2010;7:1318-1323.
61. Sette A, Martino A, Lioy E, et al. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction. J Cardiovasc Electrophysiol. 2010;21:815-817.
62. Kumar S, Vohra J. Ivabradine: appropriate treatment for inappropriate sinus tachycardia. Heart Rhythm. 2010;7:1324-1325.
63. Rakovec P. Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr. 2009;121:715-718.
64. Man KC, Knight B, Tse HF, et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol. 2000;35:451-457. (Pubitemid 30125537)
65. Marrouche NF, Beheiry S, Tomassoni G, et al. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol. 2002;39:1046-1054. (Pubitemid 34234129)
66. Shinbane JS, Lesh MD, Scheinman MN, et al. Long-term follow up after radiofrequency sinus node modification for inappropriate sinus tachycardia (abstract). J Am Coll Cardiol. 1997;29(suppl A):199A.
67. Jayaprakash S, Sparks PB, Vohra J. Inappropriate sinus tachycardia (IST): management by radiofrequency modification of sinus node. Aust N Z J Med. 1997;27:391-397.
68. Arce M, Trucco E. Taquicardia Sinusal Inapropiada. Revista Iberoamericana de Arritmología 2010; doi: http://dx.doi.org/10.5031/v1i2.RIA1091.